EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Empagliflozin Protects Against Doxorubicin Cardiotoxicity: Integrative Assessment of Cardiac Kinetics and Electrophysiology Using Machine Learning in a Rat Model

Iacob-Daniel Goje iD, Valentin Laurențiu Ordodi, Florina Maria Bojin iD, Greta-Ionela Goje iD, Alexandru Harald Bătrîn, Taddeus Paul Buica, Maria Iordache, Manuela Grijincu iD, Virgil Păunescu, Daniel-Florin Lighezan

Medical Sciences · 24.06.2026 · 14 (3) · 342

DOI: 10.3390/medsci14030342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 24.06.2026. Verfasst von Iacob-Daniel Goje und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Semiology I, "Victor Babeș" University of Medicine and Pharmacy, No. 2 Eftimie Murgu Square, 300041 Timisoara, Romania. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Cardiotoxicity, Machine Learning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “VICTOR BABES” University of Medicine and Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Anthracycline-induced cardiotoxicity remains a major challenge in cancer treatment, and researchers are showing interest in artificial intelligence (AI) to improve the prediction and detection of cancer therapy-related cardiac dysfunction (CTRCD). Current surveillance strategies rely mainly on left ventricular ejection fraction and, more recently, global longitudinal strain.

Methods

The present study was designed to evaluate cardiac performance in a rat model of doxorubicin-induced cardiotoxicity and empagliflozin-mediated cardioprotection using a machine learning-based analytical framework. Eighteen adult male Sprague–Dawley rats were assigned to five experimental groups. We aimed to quantify ventricular wall dynamics and contractility using an advanced image-processing and object-detection model that has not been previously used to distinguish normal from impaired cardiac kinetics. During real-time recording, simultaneous electrocardiogram monitoring was performed, enabling direct correlation between deep learning-based ventricular wall motion metrics and cardiac electrical activity. The cardioprotective effects of empagliflozin were further validated by immunofluorescence staining (cTnI, vimentin, α-SMA, and Cx43) of rat cardiomyocytes and paraffin-embedded cardiac tissue, demonstrating attenuation of cellular injury and structural remodeling.

Results

The integrated analysis of cardiac kinetic patterns derived via machine learning distinguishes not only extreme cardiotoxicity, but also tracks a graded pattern consistent with ECG-derived severity and treatment-related functional preservation. These findings indicate that the algorithm captures the gradient of empagliflozin’s cardioprotective effect within this internally validated preclinical setting. Additionally, immunofluorescence results validated the benefits of SGLT2 inhibition on myocardial integrity.

Conclusions

The novelty of the present work lies at the intersection of advanced cardiac kinetic analysis using AI, preclinical modeling, and SGLT2-mediated cardioprotection in cardio-oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsGlucosidesCardiotoxicityMachine LearningDoxorubicinHeartAnimalsRatsMaleRats, Sprague-DawleyDisease Models, AnimalMyocytes, CardiacElectrocardiography

Stichwörter der Autor:innen

SGLT2 inhibitorsartificial intelligencecardio-oncologycardiotoxicityimagingmachine learningstereoscopic video capture

Substanzen

Benzhydryl CompoundsGlucosidesempagliflozinDoxorubicin

Autor:innen und Institutionen

  • Department of Medical Semiology I, "Victor Babeș" University of Medicine and Pharmacy, No. 2 Eftimie Murgu Square, 300041 Timisoara, Romania.
  • Advanced Cardiology and Hemostaseology Research Center, "Victor Babeș" University of Medicine and Pharmacy, No. 2 Eftimie Murgu Square, 300041 Timisoara, Romania.
  • Department of Functional Sciences, Immuno-Physiology and Biotechnologies Center, "Victor Babeș" University of Medicine and Pharmacy, No. 2 Eftimie Murgu Square, 300041 Timisoara, Romania.
  • OncoGen-Center for Gene and Cell Therapies in Cancer Treatment, Clinical Emergency County Hospital "Pius Brinzeu" Timisoara, No. 156, Liviu Rebreanu, 300723 Timisoara, Romania.
  • Faculty of Industrial Chemistry and Environmental Engineering, "Politehnica" University Timisoara, No. 2 Victoriei Square, 300006 Timisoara, Romania.
  • Department I of Nursing, Discipline of Clinical Skills, "Victor Babeș" University of Medicine and Pharmacy, No. 2 Eftimie Murgu Square, 300041 Timisoara, Romania.

ORCID-Profile: Iacob-Daniel Goje, Florina Maria Bojin, Greta-Ionela Goje, Manuela Grijincu

Förderung

  • “VICTOR BABES” University of Medicine and Pharmacy

Zitieren

APA

Goje, I. D., Ordodi, V. L., Bojin, F. M., Goje, G. I., Bătrîn, A. H., Buica, T. P., Iordache, M., Grijincu, M., Păunescu, V., & Lighezan, D. F. (2026). Empagliflozin Protects Against Doxorubicin Cardiotoxicity: Integrative Assessment of Cardiac Kinetics and Electrophysiology Using Machine Learning in a Rat Model. Medical Sciences, 14(3), 342. https://doi.org/10.3390/medsci14030342

Vancouver

Goje ID, Ordodi VL, Bojin FM, Goje GI, Bătrîn AH, Buica TP, et al. Empagliflozin Protects Against Doxorubicin Cardiotoxicity: Integrative Assessment of Cardiac Kinetics and Electrophysiology Using Machine Learning in a Rat Model. Medical Sciences. 2026;14(3):342. doi:10.3390/medsci14030342

BibTeX
@article{Goje2026,
  author = {Goje, Iacob-Daniel and Ordodi, Valentin Laurențiu and Bojin, Florina Maria and Goje, Greta-Ionela and Bătrîn, Alexandru Harald and Buica, Taddeus Paul and Iordache, Maria and Grijincu, Manuela and Păunescu, Virgil and Lighezan, Daniel-Florin},
  title = {Empagliflozin Protects Against Doxorubicin Cardiotoxicity: Integrative Assessment of Cardiac Kinetics and Electrophysiology Using Machine Learning in a Rat Model},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {342},
  doi = {10.3390/medsci14030342}
}
Kostenlos starten →